ArcticZymes Technologies ASA (AZT.OL)
NOK 16.85
(-0.88%)
NOK 16.85
(-0.88%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -237.27 Million NOK | -4.09% |
| 2022 | -227.95 Million NOK | -25.79% |
| 2021 | -181.2 Million NOK | -42.65% |
| 2020 | -127.02 Million NOK | -834.1% |
| 2019 | -13.59 Million NOK | 16.8% |
| 2018 | -16.34 Million NOK | 42.82% |
| 2017 | -28.58 Million NOK | 49.15% |
| 2016 | -56.2 Million NOK | 26.9% |
| 2015 | -76.89 Million NOK | 11.0% |
| 2014 | -86.39 Million NOK | -165.52% |
| 2013 | -32.53 Million NOK | -383.62% |
| 2012 | -6.72 Million NOK | 81.35% |
| 2011 | -36.07 Million NOK | 16.8% |
| 2010 | -43.36 Million NOK | 12.66% |
| 2009 | -49.64 Million NOK | 60.15% |
| 2008 | -124.58 Million NOK | 17.87% |
| 2007 | -151.7 Million NOK | -137.15% |
| 2006 | -63.96 Million NOK | 32.58% |
| 2005 | -94.88 Million NOK | -627.82% |
| 2004 | -13.03 Million NOK | 7.26% |
| 2003 | -14.05 Million NOK | -458.15% |
| 2002 | -2.51 Million NOK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -160.49 Million NOK | 1.19% |
| 2024 Q1 | -162.42 Million NOK | 31.54% |
| 2023 Q4 | -237.27 Million NOK | -1.72% |
| 2023 Q2 | -225.85 Million NOK | -3.21% |
| 2023 FY | -237.27 Million NOK | -4.09% |
| 2023 Q1 | -218.83 Million NOK | 4.0% |
| 2023 Q3 | -233.25 Million NOK | -3.28% |
| 2022 Q1 | -198.87 Million NOK | -9.75% |
| 2022 Q3 | -223.72 Million NOK | -4.33% |
| 2022 Q4 | -227.95 Million NOK | -1.89% |
| 2022 FY | -227.95 Million NOK | -25.79% |
| 2022 Q2 | -214.44 Million NOK | -7.83% |
| 2021 FY | -181.2 Million NOK | -42.65% |
| 2021 Q1 | -153.39 Million NOK | -20.76% |
| 2021 Q2 | -159.18 Million NOK | -3.77% |
| 2021 Q3 | -169.32 Million NOK | -6.37% |
| 2021 Q4 | -181.2 Million NOK | -7.02% |
| 2020 Q1 | -21.52 Million NOK | -58.27% |
| 2020 Q3 | -55.91 Million NOK | -32.14% |
| 2020 Q2 | -42.31 Million NOK | -96.61% |
| 2020 Q4 | -127.02 Million NOK | -127.17% |
| 2020 FY | -127.02 Million NOK | -834.1% |
| 2019 Q2 | -4.05 Million NOK | 60.38% |
| 2019 Q3 | -5.38 Million NOK | -32.74% |
| 2019 FY | -13.59 Million NOK | 16.8% |
| 2019 Q4 | -13.59 Million NOK | -152.58% |
| 2019 Q1 | -10.23 Million NOK | 67.01% |
| 2018 Q1 | -19.96 Million NOK | 30.14% |
| 2018 Q2 | -35.16 Million NOK | -76.11% |
| 2018 Q3 | -28.15 Million NOK | 19.93% |
| 2018 FY | -16.34 Million NOK | 42.82% |
| 2018 Q4 | -31.03 Million NOK | -10.22% |
| 2017 FY | -28.58 Million NOK | 49.15% |
| 2017 Q4 | -28.58 Million NOK | 13.74% |
| 2017 Q3 | -33.13 Million NOK | 13.72% |
| 2017 Q2 | -38.4 Million NOK | 17.39% |
| 2017 Q1 | -46.48 Million NOK | 17.29% |
| 2016 Q4 | -56.2 Million NOK | 8.95% |
| 2016 FY | -56.2 Million NOK | 26.9% |
| 2016 Q2 | -64.69 Million NOK | 4.44% |
| 2016 Q1 | -67.7 Million NOK | 11.95% |
| 2016 Q3 | -61.73 Million NOK | 4.58% |
| 2015 Q2 | -78.26 Million NOK | 1.07% |
| 2015 Q3 | -76.94 Million NOK | 1.69% |
| 2015 Q1 | -79.11 Million NOK | 8.43% |
| 2015 Q4 | -76.89 Million NOK | 0.06% |
| 2015 FY | -76.89 Million NOK | 11.0% |
| 2014 Q1 | -21.75 Million NOK | 33.14% |
| 2014 Q3 | -86.66 Million NOK | 2.61% |
| 2014 Q4 | -86.39 Million NOK | 0.31% |
| 2014 Q2 | -88.98 Million NOK | -309.06% |
| 2014 FY | -86.39 Million NOK | -165.52% |
| 2013 Q1 | -44.9 Million NOK | -567.43% |
| 2013 FY | -32.53 Million NOK | -383.62% |
| 2013 Q4 | -32.53 Million NOK | 8.24% |
| 2013 Q3 | -35.46 Million NOK | 16.12% |
| 2013 Q2 | -42.27 Million NOK | 5.85% |
| 2012 Q1 | -26.54 Million NOK | 26.43% |
| 2012 FY | -6.72 Million NOK | 81.35% |
| 2012 Q2 | -19.7 Million NOK | 25.75% |
| 2012 Q3 | -12.48 Million NOK | 36.66% |
| 2012 Q4 | -6.72 Million NOK | 46.11% |
| 2011 Q1 | -45.93 Million NOK | -5.93% |
| 2011 Q2 | -42.4 Million NOK | 7.69% |
| 2011 Q3 | -41.94 Million NOK | 1.08% |
| 2011 Q4 | -36.07 Million NOK | 13.99% |
| 2011 FY | -36.07 Million NOK | 16.8% |
| 2010 Q4 | -43.36 Million NOK | 0.0% |
| 2010 FY | -43.36 Million NOK | 12.66% |
| 2009 FY | -49.64 Million NOK | 60.15% |
| 2008 FY | -124.58 Million NOK | 17.87% |
| 2007 FY | -151.7 Million NOK | -137.15% |
| 2006 FY | -63.96 Million NOK | 32.58% |
| 2005 FY | -94.88 Million NOK | -627.82% |
| 2004 FY | -13.03 Million NOK | 7.26% |
| 2003 FY | -14.05 Million NOK | -458.15% |
| 2002 FY | -2.51 Million NOK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Arctic Bioscience AS | -77.55 Million NOK | -205.948% |
| Aqua Bio Technology ASA | -5.82 Million NOK | -3970.72% |
| BerGenBio ASA | -155.55 Million NOK | -52.537% |
| Hofseth BioCare ASA | 112.89 Million NOK | 310.164% |
| PCI Biotech Holding ASA | -40.86 Million NOK | -480.641% |
| Thor Medical ASA | -41.28 Million NOK | -474.734% |
| Ultimovacs ASA | -262.84 Million NOK | 9.729% |